Ken Griffin's position in Myriad Genetics is currently worth $525 Thousand. That's 0.00% of their equity portfolio (3343rd largest holding). The first Myriad Genetics trade was made in Q2 2013. Since then Ken Griffin bought shares 48 more times and sold shares on 50 occasions. The investor's estimated purchase price is $733 Thousand, resulting in a loss of 28%.